Cargando…

Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines

Development of novel therapy strategies is one of the major pressing topics of clinical oncology to overcome drug resistance of tumors. Artesunate (ART) is an anti-malarial drug, which also exerts profound cytotoxic activity towards cancer cells. We applied a gene-hunting approach using microarray-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sertel, Serkan, Eichhorn, Tolga, Simon, Christian H., Plinkert, Peter K., Johnson, Steven W., Efferth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257326/
https://www.ncbi.nlm.nih.gov/pubmed/20428086
http://dx.doi.org/10.3390/molecules15042886
_version_ 1783374300707815424
author Sertel, Serkan
Eichhorn, Tolga
Simon, Christian H.
Plinkert, Peter K.
Johnson, Steven W.
Efferth, Thomas
author_facet Sertel, Serkan
Eichhorn, Tolga
Simon, Christian H.
Plinkert, Peter K.
Johnson, Steven W.
Efferth, Thomas
author_sort Sertel, Serkan
collection PubMed
description Development of novel therapy strategies is one of the major pressing topics of clinical oncology to overcome drug resistance of tumors. Artesunate (ART) is an anti-malarial drug, which also exerts profound cytotoxic activity towards cancer cells. We applied a gene-hunting approach using microarray-based transcriptome-wide mRNA expression profiling and COMPARE analyses. We identified a set of genes, whose expression was associated either with high IC(50) values or low IC(50) values for ART. Therefore, these genes may function as resistance or sensitivity factors for response of tumor cells towards ART. This viewpoint is conceivable for genes involved in ribosomal activity, drug transport, cellular antioxidant defense, apoptosis, cell proliferation, cell cycle progression etc. An investigation of underlying signal transduction by pathway analysis suggested a role of the signaling pathways related to tumor necrosis factor (TNF) and the tumor suppressor p53. On the other hand, there were genes without obvious functional link to cellular response to ART, such as genes involved in the survival of cochlear outer and inner hair cells etc. We proved the hypothesis that ART influences the activity of transcription factors regulating downstream genes involved or not involved in response of cancer cells towards ART. This would explain the identification of genes with and without obvious relation to the cytotoxic activity of ART by microarray and COMPARE analyses. By analysis of the binding motifs for the transcription factors c-Myc and Max, we indeed found that 53 of 56 genes contained one or more binding sites for c-Myc/Max upstream of the gene-location. We conclude that c-Myc and Max-mediated transcriptional control of gene expression might contribute to the therapeutic effects of ART in cancer cells, but may also confer unwanted side effects by affecting therapy-unrelated genes.
format Online
Article
Text
id pubmed-6257326
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Diversity Preservation International
record_format MEDLINE/PubMed
spelling pubmed-62573262018-11-30 Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines Sertel, Serkan Eichhorn, Tolga Simon, Christian H. Plinkert, Peter K. Johnson, Steven W. Efferth, Thomas Molecules Article Development of novel therapy strategies is one of the major pressing topics of clinical oncology to overcome drug resistance of tumors. Artesunate (ART) is an anti-malarial drug, which also exerts profound cytotoxic activity towards cancer cells. We applied a gene-hunting approach using microarray-based transcriptome-wide mRNA expression profiling and COMPARE analyses. We identified a set of genes, whose expression was associated either with high IC(50) values or low IC(50) values for ART. Therefore, these genes may function as resistance or sensitivity factors for response of tumor cells towards ART. This viewpoint is conceivable for genes involved in ribosomal activity, drug transport, cellular antioxidant defense, apoptosis, cell proliferation, cell cycle progression etc. An investigation of underlying signal transduction by pathway analysis suggested a role of the signaling pathways related to tumor necrosis factor (TNF) and the tumor suppressor p53. On the other hand, there were genes without obvious functional link to cellular response to ART, such as genes involved in the survival of cochlear outer and inner hair cells etc. We proved the hypothesis that ART influences the activity of transcription factors regulating downstream genes involved or not involved in response of cancer cells towards ART. This would explain the identification of genes with and without obvious relation to the cytotoxic activity of ART by microarray and COMPARE analyses. By analysis of the binding motifs for the transcription factors c-Myc and Max, we indeed found that 53 of 56 genes contained one or more binding sites for c-Myc/Max upstream of the gene-location. We conclude that c-Myc and Max-mediated transcriptional control of gene expression might contribute to the therapeutic effects of ART in cancer cells, but may also confer unwanted side effects by affecting therapy-unrelated genes. Molecular Diversity Preservation International 2010-04-22 /pmc/articles/PMC6257326/ /pubmed/20428086 http://dx.doi.org/10.3390/molecules15042886 Text en © 2010 by the authors; http://creativecommons.org/licenses/by/3.0/ licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Sertel, Serkan
Eichhorn, Tolga
Simon, Christian H.
Plinkert, Peter K.
Johnson, Steven W.
Efferth, Thomas
Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
title Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
title_full Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
title_fullStr Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
title_full_unstemmed Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
title_short Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
title_sort pharmacogenomic identification of c-myc/max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257326/
https://www.ncbi.nlm.nih.gov/pubmed/20428086
http://dx.doi.org/10.3390/molecules15042886
work_keys_str_mv AT sertelserkan pharmacogenomicidentificationofcmycmaxregulatedgenesassociatedwithcytotoxicityofartesunatetowardshumancolonovarianandlungcancercelllines
AT eichhorntolga pharmacogenomicidentificationofcmycmaxregulatedgenesassociatedwithcytotoxicityofartesunatetowardshumancolonovarianandlungcancercelllines
AT simonchristianh pharmacogenomicidentificationofcmycmaxregulatedgenesassociatedwithcytotoxicityofartesunatetowardshumancolonovarianandlungcancercelllines
AT plinkertpeterk pharmacogenomicidentificationofcmycmaxregulatedgenesassociatedwithcytotoxicityofartesunatetowardshumancolonovarianandlungcancercelllines
AT johnsonstevenw pharmacogenomicidentificationofcmycmaxregulatedgenesassociatedwithcytotoxicityofartesunatetowardshumancolonovarianandlungcancercelllines
AT efferththomas pharmacogenomicidentificationofcmycmaxregulatedgenesassociatedwithcytotoxicityofartesunatetowardshumancolonovarianandlungcancercelllines